Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | IBI351 |
| Trade Name | |
| Synonyms | GFH925|GFH-925|GFH 925|IBI 351|IBI-351|Fulzerasib |
| Drug Descriptions |
IBI351 is a KRAS G12C inhibitor, which potentially decreases tumor growth (PMID: 39127176). |
| DrugClasses | KRAS G12C inhibitor 36 |
| CAS Registry Number | NA |
| NCIT ID | C182070 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Cetuximab + IBI351 | Cetuximab IBI351 | 0 | 1 |
| IBI351 | IBI351 | 0 | 0 |